# IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

> **NCT06688175** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 32 (estimated)

## Conditions studied

- Nasopharyngeal Neoplasms
- Elderly
- Chemotherapy

## Interventions

- **DRUG:** IMRT combined with lobaplatin-based concurrent chemotherapy

## Key facts

- **NCT ID:** NCT06688175
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-11-13
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06688175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06688175, "IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06688175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*